John R. Mackey

1996–2025 年に発表

161
論文数
36,159
被引用数
101
h 指数
157
i10 指数

被引用数

John R. Mackey の年別被引用数1998 年: 被引用 3 件1999 年: 被引用 5 件2000 年: 被引用 13 件2001 年: 被引用 51 件2002 年: 被引用 53 件2003 年: 被引用 87 件2004 年: 被引用 121 件2005 年: 被引用 124 件2006 年: 被引用 171 件2007 年: 被引用 173 件2008 年: 被引用 230 件2009 年: 被引用 263 件2010 年: 被引用 325 件2011 年: 被引用 374 件2012 年: 被引用 468 件2013 年: 被引用 492 件2014 年: 被引用 463 件2015 年: 被引用 540 件2016 年: 被引用 475 件2017 年: 被引用 417 件2018 年: 被引用 361 件2019 年: 被引用 1,148 件2020 年: 被引用 1,065 件2021 年: 被引用 972 件2022 年: 被引用 714 件2023 年: 被引用 539 件2024 年: 被引用 776 件2025 年: 被引用 357 件2026 年: 被引用 7 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,413 件、この内訳の 24.7%中国: 引用元論文 1,041 件、この内訳の 7.5%カナダ: 引用元論文 1,038 件、この内訳の 7.5%イギリス: 引用元論文 921 件、この内訳の 6.7%イタリア: 引用元論文 739 件、この内訳の 5.4%ドイツ: 引用元論文 590 件、この内訳の 4.3%フランス: 引用元論文 495 件、この内訳の 3.6%オーストラリア: 引用元論文 476 件、この内訳の 3.5%スペイン: 引用元論文 406 件、この内訳の 2.9%オランダ: 引用元論文 354 件、この内訳の 2.6%日本: 引用元論文 330 件、この内訳の 2.4%韓国: 引用元論文 309 件、この内訳の 2.2%
0%24.7%その他 26.7%

分野

  • Medicine63%
  • Biochemistry, Genetics and Molecular Biology28.6%
  • Immunology and Microbiology2.3%
  • Computer Science0.9%
  • Engineering0.8%
  • Materials Science0.8%
  • その他3.6%

トピック

  • Cancer survivorship and care5%
  • HER2/EGFR in Cancer Research3.7%
  • Breast Cancer Treatment Studies3.7%
  • Cancer Treatment and Pharmacology2.9%
  • Nutrition and Health in Aging2.9%
  • Chemotherapy-induced cardiotoxicity and mitigation2.6%
  • その他79.2%

共著者

全論文

検索で開く
  1. Adjuvant Trastuzumab in HER2-Positive Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 被引用: 2,775

  2. Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2022 被引用: 223

  3. The clonal and mutational evolution spectrum of primary triple-negative breast cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Malachi Griffith, Annie Moradian, Siwei Cheng, Gregg B. Morin, Peter H. Watson, Karen A. Gelmon, Stephen Chia, Suet‐Feung Chin, Christina Curtis, Oscar M. Rueda, Paul D.P. Pharoah, Sambasivarao Damaraju, John R. Mackey, Kelly Hoon, Timothy T. Harkins, Vasisht Tadigotla, Mahvash Sigaroudinia, Philippe Gascard, Thea D. Tlsty, J Costello, Irmtraud M. Meyer, Connie J. Eaves, Wyeth W. Wasserman, Steven J.M. Jones, David G. Huntsman, Martin Hirst, Carlos Caldas, Marco A. Marra, Samuel Aparício - Nature 2012 被引用: 2,036

  4. Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment

    著者: , , , , , , , , , - Clinical Cancer Research 2009 被引用: 1,111

  5. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Toru Watanabe, Greg Yothers, Ke‐Da Yu, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Lucy Davies, Frances Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Lui, Zulian Lui, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Aman U. Buzdar, Vera J. Suman, Kelly K. Hunt, Robert Leonard, Janine Mansi, Catherine Delbaldo, Pascal Piedbois, Emmanuel Quinaux, Christian Fesl, Michael Gnant, Lidija Sölkner, Guenther G. Steger, Hans Petter Eikesdal, Per Eystein Lønning, Valerie Bée, Helena Fung, John R. Mackey, Miguel Martín, Michael F. Press, Evandro de Azambuja, Richard D. Gelber, Meredith M. Regan, Angelo Di Leo, Veerle Van Dooren, J.-M. Nogaret, John M.S. Bartlett, Bingshu E. Chen, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Kathleen I. Pritchard, Lois E. Shepherd, Donald A. Berry, Constance Cirrincione, Lawrence N. Shulman, Eric P. Winer, Rebecca Gelman, Jay R. Harris, Craig Henderson, Charles L. Shapiro, Peer Christiansen, Marianne Ewertz, Henning T. Mouridsen, Elise Van Leeuwen, Sabine C. Linn, Annelot G.J. van Rossum, Harm van Tinteren ほか 136 名 - The Lancet 2023 被引用: 189

  6. Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christina Davies, Frances Duane, Vaughan Evans, Lucy Gettins, Jon Godwin, Robert K. Hills, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Yaochen Wang, Zhe Wang, Peter A. Fasching, Nadia Harbeck, Pascal Piedbois, Michael Gnant, Guenther G. Steger, Angelo Di Leo, Stella Dolci, Prue Francis, Denis Larsimont, J.-M. Nogaret, C. Philippson, Martine Piccart, Sabine C. Linn, Petronella G.M. Peer, Vivianne C. G. Tjan‐Heijnen, S.B. Vliek, John R. Mackey, Dennis Slamon, John M.S. Bartlett, Vivien Bramwell, Bingshu E. Chen, Stephen Chia, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Joseph L. Pater, Eileen Rakovitch, Lois E. Shepherd, Dongsheng Tu, Timothy J. Whelan, Donald A. Berry, Gloria Broadwater, Constance Cirrincione, Hyman B. Muss, Raymond L. Weiss, Yi Shan, Yong fu Shao, Xiang Wang, Binghe Xu, Dongbing Zhao, Harry Bartelink, Nina Bijker, Jan Bogaerts, Fátima Cardoso, Tanja Čufer, Jean‐Pierre Julien, Philip Poortmans, Emiel J. Rutgers, Cornelis J.�H. van de Velde, Eva Carrasco, Miguel Ángel Seguí, Jens‐Uwe Blohmer, Serban Dan Costa, Bernd Gerber ほか 67 名 - The Lancet 2019 被引用: 394

  7. Effects of Aerobic and Resistance Exercise in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Multicenter Randomized Controlled Trial

    著者: , , , , , , , , , , , - Journal of Clinical Oncology 2007 被引用: 1,172

  8. Incident Cardiovascular Disease Among Adults With Cancer

    著者: , , , , , , - JACC CardioOncology 2022 被引用: 183

  9. Metabolic Modulation of Glioblastoma with Dichloroacetate

    著者: , , , , , , , , , , , , - Science Translational Medicine 2010 被引用: 715

  10. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer

    著者: , , - British Journal of Cancer 2008 被引用: 651

  11. Cardiopulmonary Function and Age-Related Decline Across the Breast Cancer Survivorship Continuum

    著者: , , , , , , , , , , - Journal of Clinical Oncology 2012 被引用: 437

  12. Effects of Exercise during Adjuvant Chemotherapy on Breast Cancer Outcomes

    著者: , , , , , , , , , - Medicine & Science in Sports & Exercise 2014 被引用: 267

  13. Targeting N-myristoylation for therapy of B-cell lymphomas

    著者: , , , , , , , , , , , , , , , , , - Nature Communications 2020 被引用: 66

  14. Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study

    著者: , , , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 850

  15. Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity

    著者: , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 401

  16. Effects of Exercise Dose and Type During Breast Cancer Chemotherapy: Multicenter Randomized Trial

    著者: , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2013 被引用: 301

  17. Randomized Controlled Trial of Exercise Training in Postmenopausal Breast Cancer Survivors: Cardiopulmonary and Quality of Life Outcomes

    著者: , , , , , - Journal of Clinical Oncology 2003 被引用: 756

  18. Nucleoside analogues and nucleobases in cancer treatment

    著者: , , - The Lancet Oncology 2002 被引用: 606

  19. Presentation and management of docetaxel-related adverse effects in patients with breast cancer

    著者: , - Cancer Management and Research 2014 被引用: 214

  20. Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial

    著者: , , , , , , , , , - Breast Cancer Research and Treatment 2016 被引用: 169

  21. Early Breast Cancer Therapy and Cardiovascular Injury

    著者: , , , , - Journal of the American College of Cardiology 2007 被引用: 451

  22. Association of FABP5 Expression With Poor Survival in Triple-Negative Breast Cancer

    著者: , , , , , - American Journal Of Pathology 2011 被引用: 165

  23. Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2016 被引用: 104

  24. Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230

    著者: , , , , , , , , - Journal of Clinical Oncology 2008 被引用: 407